BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3394572)

  • 21. Central histaminergic stimulation of corticosterone and hyperlipemic responses after chronic ethanol consumption in rats.
    Gadek A; Cetera B; Bugajski J
    Agents Actions; 1987 Apr; 20(3-4):258-61. PubMed ID: 3604805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-fluoromethylhistidine decreases the Leu-enkephalinamide- and morphine-induced corticosterone response in rats.
    Turon M; Fogel WA; Bugajski J
    Pharmacology; 1991; 42(4):188-96. PubMed ID: 1712972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central histaminergic effect on basal and opioid-induced prolactin secretion.
    Castro-e-Silva E; Antunes-Rodrigues J
    Braz J Med Biol Res; 1988; 21(2):345-51. PubMed ID: 3203168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histaminergic components in carbachol-induced pituitary-adrenocortical activity.
    Bugajski J; Gadek-Michalska A; Borycz J; Bugajski AJ; Głód R
    J Physiol Pharmacol; 1994 Sep; 45(3):419-28. PubMed ID: 7841454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central metabolic and pituitary-adrenocortical stimulatory action of histamine and clonidine.
    Bugajski J
    Pol J Pharmacol Pharm; 1984; 36(2-3):159-76. PubMed ID: 6089156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulatory effect of intracerebroventricular met- and leu-enkephalin on corticosterone secretion in rats.
    Gadek-Michalska A; Bugajski J
    Folia Med Cracov; 1996; 37(3-4):3-12. PubMed ID: 9269123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic effect of naloxone on the hypertensive response of intraventricularly administered histamine.
    Młynarska MS
    Agents Actions; 1990 Apr; 30(1-2):226-30. PubMed ID: 2142565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of histamine, cimetidine and pyrilamine on naloxone-induced jumping in morphine-dependent mice.
    Zarrindast MR; Assadi E; Oryan S; Torkaman-Boutorabi A; Sahebgharani M
    Eur J Pharmacol; 2003 Jun; 471(2):105-12. PubMed ID: 12818697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central histaminergic mechanisms in the corticosterone response to clonidine.
    Bugajski J; Gadek-Michalska A; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1993 Sep; 44(3):303-12. PubMed ID: 8241531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intracerebroventricularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats.
    Gadek-Michalska A; Chłap Z; Turoń M; Bugajski J; Fogel WA
    Agents Actions; 1991 Mar; 32(3-4):203-8. PubMed ID: 1862742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary-adrenocortical responsiveness to histaminergic stimulation during social stress of crowding in rats.
    Gadek-Michalska A; Borycz J; Bugajski J
    Agents Actions; 1994 Jun; 41 Spec No():C80-1. PubMed ID: 7976812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The involvement of central histamine receptors in stress-induced responses of serum corticosterone and free fatty acids and in gastric ulcer development.
    Bugajski J; Gadek A
    Agents Actions; 1981 Apr; 11(1-2):151-5. PubMed ID: 6113742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.
    Erfanparast A; Tamaddonfard E; Taati M; Dabaghi M
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1089-96. PubMed ID: 26077661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of nitric oxide in central histaminergic stimulation of the hypothalamic-pituitary-adrenal axis.
    Bugajski AJ; Koprowska B; Thor P; Głod R; Bugajski J
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):907-15. PubMed ID: 11220498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central histaminergic stimulation of hyperlipemic response in rats under stress.
    Bugajski J; Gadek A
    Agents Actions; 1985 Apr; 16(3-4):236-9. PubMed ID: 2861733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of adrenergic and cholinergic antagonists on central histaminergic stimulation of pituitary-adrenocortical response under stress in rats.
    Bugajski J; Gadek A
    Neuroendocrinology; 1984 Jun; 38(6):447-52. PubMed ID: 6738809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of naloxone on central adrenergic stimulation of corticosterone secretion.
    Gadek-Michalska A; Turoń M; Bugajski J
    Folia Med Cracov; 1997; 38(3-4):37-45. PubMed ID: 10481380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of histamine and opioid systems on memory retention of passive avoidance learning in rats.
    Zarrindast MR; Eidi M; Eidi A; Oryan S
    Eur J Pharmacol; 2002 Oct; 452(2):193-7. PubMed ID: 12354569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.